Exhibit 99.3
1345 AVENUE OF THE AMERICAS, 11th FLOOR NEW YORK, NEW YORK 10105 TELEPHONE: (212) 370-1300 FACSIMILE: (212) 370-7889 www.egsllp.com |
December 1, 2021
FILED VIA SEDAR
Ontario Securities Commission
Alberta Securities Commission
British Columbia Securities Commission
The Manitoba Securities Commission
Dear Sirs/Mesdames,
Re: | Skylight Health Group Inc. (the “Issuer”) |
Issuer Profile No.: 45044
- Prospectus Supplement dated December 1, 2021 (the “Prospectus Supplement”) to Amended & Restated Short Form Base Shelf Prospectus dated October 4, 2021 (the “Offering”)
FILE NO. 117307
We refer to the Prospectus Supplement of Skylight Health Group Inc. dated December 1, 2021 relating to the distribution of 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares.
We hereby consent to the references to our firm name on page (iii) of the Prospectus Supplement and under the heading “Interest of Experts”.
We confirm that we have read the Prospectus Supplement and have no reason to believe that there are any misrepresentations in the information contained in it that are within our knowledge as a result of the services we performed in connection with the preparation of the Prospectus.
Yours truly,
/s/ Ellenoff Grossman & Schole LLP
Ellenoff Grossman & Schole LLP